The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Cardiotoxicity of Anthracyclines
Open accessAbstract
Cardiotoxicity is a relevant complication that may compromise the clinical use of anthracyclines, affecting the quality of life and overall survival in cancer patients, independently of the oncological prognosis. The paper provides an overview of anthracycline-induced cardiotoxicity in terms of definition, classification, incidence, risk factors, possible mechanisms, diagnosis, and treatment. We also reported effective strategies for preventing cardiotoxicity. Furthermore, we discussed the limitation of current approaches, the need for a new classification, for early detection and treatment of cardiotoxicity. Probably, anthracycline-induced cardiotoxicity is a unique and continuous phenomenon starting with myocardial cell injury, followed by progressive left ventricular ejection fraction (LVEF) decline that, if disregarded and not cured progressively leads to overt heart failure. Anthracycline-induced cardiotoxicity can be detected at an early preclinical phase, very much before the onset of heart failure symptoms or before LVEF drops. The role of troponins in identifying subclinical cardiotoxicity and treatment with angiotensin-converting enzyme inhibitors to prevent LVEF reduction is an effective strategy that has emerged in the last fifteen years. If cardiac dysfunction has already occurred, partial or complete LVEF recovery may still be obtained if cardiotoxicity is detected early and heart failure treatment is promptly initiated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Self-citationUnderlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,723
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,414
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Anthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
Self-citationThavendiranathan, P., Poulin, F., Lim, K.-D., Plana, J. C., Woo, A., & Marwick, T. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.073 · Cited by 1,079
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu192 · Cited by 1,058
Self-citationCardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,026
Self-citationCardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Cardinale, D., Sandri, M. T., Colombo, A., Colombo, N., Boeri, M., Lamantia, G., Civelli, M., Peccatori, F., Martinelli, G., Fiorentini, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130926.51766.cc · Cited by 955
Self-citationMehta, L. S., Watson, K. E., Barac, A., Beckie, T. M., Bittner, V., Cruz-Flores, S., Dent, S., Kondapalli, L., Ky, B., Okwuosa, T., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000556 · Cited by 848
Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., Cohen, V., Banchs, J., Carver, J. R., Wiegers, S. E., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.973321 · Cited by 814
Smith, L. A., Cornelius, V. R., Plummer, C. J., Levitt, G., Verrill, M., Canney, P., & Jones, A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-337 · Cited by 753
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Curigliano, G., Cardinale, D., Dent, S., Criscitiello, C., Aseyev, O., Lenihan, D., & Cipolla, C. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 723
Self-citationProtective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Cohen, V., Gosavi, S., Carver, J. R., Wiegers, S. E., Martin, R. P., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.006 · Cited by 682
Prevention of Anthracycline-Induced Cardiotoxicity
Vejpongsa, P., & Yeh, E. T. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1167 · Cited by 671
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Cardinale, D., Colombo, A., Torrisi, R., Sandri, M. T., Civelli, M., Salvatici, M., Lamantia, G., Colombo, N., Cortinovis, S., Dessanai, M. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3615 · Cited by 641
Self-citationBosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales-Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Schmidinger, M., Zielinski, C. C., Vogl, U. M., Bojic, A., Bojic, M., Schukro, C., Ruhsam, M., Hejna, M., & Schmidinger, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6331 · Cited by 615
Ky, B., Putt, M., Sawaya, H., French, B., Januzzi, J. L., Sebag, I. A., Plana, J. C., Cohen, V., Banchs, J., Carver, J. R., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.061 · Cited by 563
Cardioprotective interventions for cancer patients receiving anthracyclines
van Dalen, E. C., Caron, H. N., Dickinson, H. O., & Kremer, L. C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003917.pub4 · Cited by 553
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Tricca LabTech, A., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Cipolla, C. M., & Fiorentini, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00748-8 · Cited by 551
Self-citationAnthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
Henriksen, P. A. (2018) · Heart · doi:10.1136/heartjnl-2017-312103 · Cited by 536
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Avila, M. S., Ayub-Ferreira, S. M., de Barros Wanderley, M. R., das Dores Cruz, F., Gonçalves Brandão, S. M., Rigaud, V. O. C., Higuchi-dos-Santos, M. H., Hajjar, L. A., Kalil Filho, R., Hoff, P. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.049 · Cited by 507
Lipshultz, S. E., Scully, R. E., Lipsitz, S. R., Sallan, S. E., Silverman, L. B., Miller, T. L., Barry, E. V., Asselin, B. L., Athale, U., Clavell, L. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70204-7 · Cited by 446
Eschenhagen, T., Force, T., Ewer, M. S., de Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J.-L., Brutsaert, D. L., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq213 · Cited by 413
Pituskin, E., Mackey, J. R., Koshman, S., Jassal, D., Pitz, M., Haykowsky, M. J., Pagano, J. J., Chow, K., Thompson, R. B., Vos, L. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.7830 · Cited by 408
Drafts, B. C., Twomley, K. M., D'Agostino, R., Lawrence, J., Avis, N., Ellis, L. R., Thohan, V., Jordan, J., Melin, S. A., Torti, F. M., et al. (2013) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2012.11.017 · Cited by 391
Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury
Lipshultz, S. E., Rifai, N., Sallan, S. E., Lipsitz, S. R., Dalton, V., Sacks, D. B., & Ottlinger, M. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2641 · Cited by 384
Epidemiology of anthracycline cardiotoxicity in children and adults.
Ma, G., & Se, L. (1998) · PubMed · Cited by 341
Jensen, B. V., Skovsgaard, T., & Nielsen, S. L. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf132 · Cited by 336
Bloom, M. W., Hamo, C. E., Cardinale, D., Ky, B., Nohria, A., Baer, L., Skopicki, H., Lenihan, D. J., Gheorghiade, M., Lyon, A. R., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002661 · Cited by 334
Self-citationSeicean, S., Seicean, A., Plana, J. C., Budd, G. T., & Marwick, T. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.067 · Cited by 326
Kaya, M. G., Ozkan, M., Gunebakmaz, O., Akkaya, H., Kaya, E. G., Akpek, M., Kalay, N., Dikilitas, M., Yarlioglues, M., Karaca, H., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.023 · Cited by 325
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Borghini, E., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Fiorentini, C., & Cipolla, C. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf170 · Cited by 313
Self-citationRafiyath, S. M., Rasul, M., Lee, B., Wei, G., Lamba, G., & Liu, D. (2012) · Experimental Hematology & Oncology · doi:10.1186/2162-3619-1-10 · Cited by 302
O’Brien, P. J. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.006 · Cited by 270
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
Akpek, M., Ozdogru, I., Sahin, O., Inanc, M., Dogan, A., Yazici, C., Berk, V., Karaca, H., Kalay, N., Oguzhan, A., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.196 · Cited by 258
Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
Acar, Z., Kale, A., Turgut, M., Demircan, S., Durna, K., Demir, S., Meriç, M., & Ağaç, M. T. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.025 · Cited by 255
Sandri, M. T., Salvatici, M., Cardinale, D., Zorzino, L., Passerini, R., Lentati, P., Leon, M., Civelli, M., Martinelli, G., & Cipolla, C. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050153 · Cited by 250
Self-citationCardinale, D., Ciceri, F., Latini, R., Franzosi, M. G., Sandri, M. T., Civelli, M., Cucchi, G., Menatti, E., Mangiavacchi, M., Cavina, R., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.02.005 · Cited by 239
Self-citationOliveira, P. J., Bjork, J. A., Santos, M. S., Leino, R. L., Froberg, M. K., Moreno, A. J., & Wallace, K. B. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.005 · Cited by 227
Asselin, B. L., Devidas, M., Chen, L., Franco, V. I., Pullen, J., Borowitz, M. J., Hutchison, R. E., Ravindranath, Y., Armenian, S. H., Camitta, B. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.8851 · Cited by 204
Brown, J., Jenkins, C., & Marwick, T. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.08.032 · Cited by 193
Levis, B. E., Binkley, P. F., & Shapiro, C. L. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30535-1 · Cited by 184
Doxorubicin targets multiple players: A new view of an old problem
Cappetta, D., Rossi, F., Piegari, E., Quaini, F., Berrino, L., Urbanek, K., & De Angelis, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.016 · Cited by 183
Putt, M., Hahn, V. S., Januzzi, J. L., Sawaya, H., Sebag, I. A., Plana, J. C., Picard, M. H., Carver, J. R., Halpern, E. F., Kuter, I., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241232 · Cited by 178
Narayan, H. K., Finkelman, B., French, B., Plappert, T., Hyman, D., Smith, A. M., Margulies, K. B., & Ky, B. (2017) · Circulation · doi:10.1161/circulationaha.116.023463 · Cited by 173
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
Macedo, A. V. S., Hajjar, L. A., Lyon, A. R., Nascimento, B. R., Putzu, A., Rossi, L., Costa, R. B., Landoni, G., Nogueira-Rodrigues, A., & Ribeiro, A. L. P. (2019) · JACC: CardioOncology · doi:10.1016/j.jaccao.2019.08.003 · Cited by 170
cTnT can be a useful marker for early detection of anthracycline cardiotoxicity
Kilickap, S., Barista, I., Akgul, E., Aytemir, K., Aksoyek, S., Aksoy, S., Celik, I., Kes, S., & Tekuzman, G. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi152 · Cited by 167
Seicean, S., Seicean, A., Alan, N., Plana, J. C., Budd, G. T., & Marwick, T. H. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000055 · Cited by 165
Zardavas, D., Suter, T. M., Van Veldhuisen, D. J., Steinseifer, J., Noe, J., Lauer, S., Al-Sakaff, N., Piccart-Gebhart, M. J., & de Azambuja, E. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7916 · Cited by 164
Reichardt, P., Tabone, M.-D., Mora, J., Morland, B., & Jones, R. L. (2018) · Future Oncology · doi:10.2217/fon-2018-0210 · Cited by 160
Cadeddu, C., Piras, A., Mantovani, G., Deidda, M., Dessì, M., Madeddu, C., Massa, E., & Mercuro, G. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.05.037 · Cited by 159
Doherty, J. U., Kort, S., Mehran, R., Schoenhagen, P., Soman, P., DEHMER, G. J., Doherty, J. U., Schoenhagen, P., Bashore, T. M., Bhave, N. M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.038 · Cited by 157
Vaduganathan, M., Hirji, S. A., Qamar, A., Bajaj, N. S., Gupta, A., Zaha, V. G., Chandra, A., Haykowsky, M. J., Ky, B., Moslehi, J. J., et al. (2019) · JACC CardioOncology · doi:10.1016/j.jaccao.2019.08.006 · Cited by 154
Negishi, T., Thavendiranathan, P., Negishi, K., Marwick, T. H., Aakhus, S., Murbræch, K., Massey, R. J., Bansal, M., Fukuda, N., Hristová, K., et al. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.03.019 · Cited by 142
Oncocardiology—Past, Present, and Future
Yeh, E. T. H., & Chang, H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2132 · Cited by 134
Chotenimitkhun, R., D'Agostino, R., Lawrence, J. A., Hamilton, C. A., Jordan, J. H., Vasu, S., Lash, T. L., Yeboah, J., Herrington, D. M., & Hundley, W. G. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.11.020 · Cited by 126
Sandri, M. T., Cardinale, D. M., Zorzino, L., Passerini, R., Lentati, P., Martinoni, A., Martinelli, G., & Cipolla, C. M. (2003) · Clinical Chemistry · doi:10.1373/49.2.248 · Cited by 123
Self-citationGalectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction
Weir, R. A. P., Petrie, C. J., Murphy, C. A., Clements, S. E., Steedman, T., Miller, A. M., McInnes, I. B., Squire, I. B., Ng, L. L., Dargie, H. J., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000146 · Cited by 105
van Dalen, E. C., van der Pal, H. J. H., & Kremer, L. C. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005008.pub4 · Cited by 103
Response of Doxorubicin-induced Cardiomyopathy to the Current Management Strategy of Heart Failure
Tallaj, J. A., Franco, V., Rayburn, B. K., Pinderski, L. J., Benza, R. L., Pamboukian, S. V., Foley, B. A., & Bourge, R. C. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.12.108 · Cited by 100
Mornoş, C., & Petrescu, L. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0398 · Cited by 96
Liu, J., Banchs, J. A., Mousavi, N., et al. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.03.025 · Cited by 96
Gulati, G., Heck, S. L., Røsjø, H. R., Ree, A. H., Hoffmann, P., Hagve, T., Norseth, J., Gravdehaug, B., Steine, K., Geisler, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006513 · Cited by 93
Lenihan, D. J., Stevens, P. L., Massey, M., Plana, J. C., Araujo, D. M., Fanale, M. A., Fayad, L., Fisch, M. J., & Yeh, E. T. H. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.04.003 · Cited by 91
Frères, P., Bouznad, N., Servais, L., Josse, C., Wenric, S., Poncin, A., Thiry, J., Moonen, M. L., Oury, C., Lancellotti, P., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4015-4 · Cited by 84
Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss
Cardinale, D. M., Biasillo, G., & Cipolla, C. M. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0731-z · Cited by 82
Self-citationManagement of Cardiovascular Disease in Women With Breast Cancer
Barish, R. M. B., Lynce, F. C., Unger, K. R., & Barac, A. (2019) · Circulation · doi:10.1161/circulationaha.118.039371 · Cited by 81
Reversibility of Severe Left Ventricular Dysfunction Due to Doxorubicin Cardiotoxicity
Saini, J., RICH, M. W., & LYSS, A. P. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-814 · Cited by 79
Screening for Cardiac Dysfunction in Anthracycline-Exposed Childhood Cancer Survivors
Armenian, S. H., Gelehrter, S. K., Vase, T., Venkatramani, R., Landier, W., Wilson, K. D., Herrera, C., Reichman, L., Menteer, J.-D., Mascarenhas, L., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3490 · Cited by 75
Twisting and Ironing: Doxorubicin Cardiotoxicity by Mitochondrial DNA Damage
Nitiss, K. C., & Nitiss, J. L. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0821 · Cited by 71
van Boxtel, W., Bulten, B. F., Mavinkurve‐Groothuis, A. M. C., Bellersen, L., Mandigers, C. M. P. W., Joosten, L. A. B., Kapusta, L., de Geus‐Oei, L., & van Laarhoven, H. W. M. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1040839 · Cited by 61
Preventive Cardio-Oncology: The Time Has Come
Brown, S.-A. N. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00187 · Cited by 59
Clinical Correlation between Brain Natriutetic Peptide and Anthracyclin-induced Cardiac Toxicity
Lee, H. S., Son, C. B., Shin, S. H., & Kim, Y. S. (2008) · Cancer Research and Treatment · doi:10.4143/crt.2008.40.3.121 · Cited by 48
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
Audebrand, A., Désaubry, L., & Nebigil, C. G. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00194 · Cited by 26
The breast cancer patient in the cardioncology unit
Cardinale, D. M., Caruso, V., & Cipolla, C. M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.10.06 · Cited by 20
Self-citationHoeger, C. W., & Hayek, S. S. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.07.015 · Cited by 18
Cardiovascular Prevention Strategies in Breast Cancer
Yin, A., Brewster, A. M., Barac, A., Thoman, W. S., Oeffinger, K. C., & Gilchrist, S. C. (2019) · JACC CardioOncology · doi:10.1016/j.jaccao.2019.09.001 · Cited by 11
Cited by
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
Anthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
Self-citationPituskin, E., Mackey, J. R., Koshman, S., Jassal, D., Pitz, M., Haykowsky, M. J., Pagano, J. J., Chow, K., Thompson, R. B., Vos, L. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.7830 · Cited by 408
Bloom, M. W., Hamo, C. E., Cardinale, D., Ky, B., Nohria, A., Baer, L., Skopicki, H., Lenihan, D. J., Gheorghiade, M., Lyon, A. R., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002661 · Cited by 334
Self-citationWilliams, S. A., Ostroff, R., Hinterberg, M. A., Coresh, J., Ballantyne, C. M., Matsushita, K., Mueller, C. E., Walter, J., Jonasson, C., Holman, R. R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj9625 · Cited by 97
Metadata
- Authors
- Cardinale, D., Iacopo, F., & Cipolla, C. M.
- Venue
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Published
- 2020-03-18
- Volume
- 7
- ISSN
- 2297-055X (ISSN-L)
- OpenAlex
- W4294605240
- Cited by
- 463
- References
- 83
- FWCI
- 31.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.